These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 35848578)

  • 21. Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients.
    Gold JE; Baumgartl WH; Okyay RA; Licht WE; Fidel PL; Noverr MC; Tilley LP; Hurley DJ; Rada B; Ashford JW
    mBio; 2020 Nov; 11(6):. PubMed ID: 33219096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated measles, mumps, rubella, and varicella zoster virus vaccine (Priorix-Tetra).
    Dhillon S; Curran MP
    Paediatr Drugs; 2008; 10(5):337-47. PubMed ID: 18754700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Booster immune response in children 6-7 years of age, randomly assigned to four groups with two MMR vaccines applied by aerosol or by injection.
    Díaz-Ortega JL; Bennett JV; Castañeda-Desales D; Quintanilla DM; Martínez D; de Castro JF
    Vaccine; 2014 Jun; 32(29):3680-6. PubMed ID: 24837512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination.
    Matter L; Germann D; Bally F; Schopfer K
    Eur J Epidemiol; 1997 Jan; 13(1):61-6. PubMed ID: 9062781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
    McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
    MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
    Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
    Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Live (vaccines) from New York.
    Forlenza CJ; Small TN
    Bone Marrow Transplant; 2013 Jun; 48(6):749-54. PubMed ID: 22890288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    Krow-Lucal E; Marin M; Shepersky L; Bahta L; Loehr J; Dooling K
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(46):1465-1470. PubMed ID: 36395065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful restoration of protective immunity against measles, mumps, and rubella following MMR vaccination in adult hematopoietic cell transplant recipients.
    Lin RY; Anderson AD; Morris MI; Raja M; Komanduri KV; Camargo JF
    Transpl Infect Dis; 2023 Apr; 25(2):e14043. PubMed ID: 36880572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Quality analysis of a combined domestic vaccine for the prevention of measles, rubella and mumps].
    Binyatova AS; Unasova TN; Iliasova TN; Sarkisyan KА; Fadeikina OV; Movsesyants AA
    Vopr Virusol; 2022 Nov; 67(5):414-422. PubMed ID: 36515287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines such as the MMR (Measles-Mumps-Rubella) against COVID-19 in Brazil: a missed chance?
    Araújo A; Lins-Kusterer L; Netto E
    An Acad Bras Cienc; 2023; 95(suppl 1):e20220924. PubMed ID: 36820732
    [No Abstract]   [Full Text] [Related]  

  • 34. A combination vaccine against measles, mumps, rubella and varicella.
    Knuf M; Faber J; Barth I; Habermehl P
    Drugs Today (Barc); 2008 Apr; 44(4):279-92. PubMed ID: 18536786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measles, Mumps, and Rubella Serostatus and Response to MMR Vaccination Among HIV-Infected Adults.
    Singh HK; Chiu YL; Wilkin T
    AIDS Patient Care STDS; 2015 Sep; 29(9):461-4. PubMed ID: 26153909
    [No Abstract]   [Full Text] [Related]  

  • 36. The virtual elimination of rubella and mumps from the United States and the use of combined measles, mumps and rubella vaccines (MMR) to eliminate measles.
    Bart KJ; Orenstein WA; Hinman AR
    Dev Biol Stand; 1986; 65():45-52. PubMed ID: 3104117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new measles mumps rubella (MMR) vaccine: a randomized comparative trial for assessing the reactogenicity and immunogenicity of three consecutive production lots and comparison with a widely used MMR vaccine in measles primed children.
    Lee CY; Tang RB; Huang FY; Tang H; Huang LM; Bock HL
    Int J Infect Dis; 2002 Sep; 6(3):202-9. PubMed ID: 12718836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of non-specific hospitalised infections following MMR vaccination given with and without inactivated vaccines in the second year of life. Comparative self-controlled case-series study in England.
    Andrews N; Stowe J; Thomas SL; Walker JL; Miller E
    Vaccine; 2019 Aug; 37(36):5211-5217. PubMed ID: 31375437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [35-year measles, mumps, rubella vaccination assessment in France].
    Reinert P; Soubeyrand B; Gauchoux R
    Arch Pediatr; 2003 Nov; 10(11):948-54. PubMed ID: 14613687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.